Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
Drug-coated balloons (DCBs) have become an established therapy for the treatment of above-the-knee peripheral artery disease. The paclitaxel DCB has shown clinical benefit in terms of patency and freedom from re-intervention in multiple randomised trials. However, a recent meta-analysis has suggeste...
Main Authors: | Masayuki Mori, Atsushi Sakamoto, Rika Kawakami, Yu Sato, Hiroyuki Jinnouchi, Kenji Kawai, Anne Cornelissen, Renu Virmani, Aloke V Finn |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-04-01
|
Series: | Vascular and Endovascular Review |
Online Access: | https://www.verjournal.com/articles/paclitaxel-and-sirolimus-coated-balloons |
Similar Items
-
Calcification in human vessels and valves: from pathological point of view
by: Yu Sato, et al.
Published: (2020-12-01) -
Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View
by: Atsushi Sakamoto, et al.
Published: (2018-09-01) -
New insights into the role of iron in inflammation and atherosclerosis
by: Anne Cornelissen, et al.
Published: (2019-09-01) -
Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
by: Ulf Teichgräber, et al.
Published: (2021-09-01) -
IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
by: Torii S, et al.
Published: (2019-02-01)